Vaccines and Related Biological Products Advisory Committee

Dynavax Technologies Corporation has announced an Advisory Committee meeting for HEPLISAV-B™ [Hepatitis B Vaccine, Recombinant (Adjuvanted)]. Note: Tarius will draft a Background Analysis for this meeting within 5 days of when the meeting is announced by the FDA.